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The incidence of thromboembolic diseases is increasing, and they are a major cause of mortality and
morbidity worldwide. Mediterranean diet is known for its high content of olive products, especially olive oil,
which has known cardiovascular health benefits, including those on blood pressure, cholesterol level, and
thrombogenesis. All previous animal and clinical studies investigating the beneficial antithrombotic effects of
olives have focused on olive oil and a few on olive leaves (OLEs). In this study, the ethanolic extract of OLE
was evaluated for its antithrombotic activity in the rabbit model of thrombosis induced by ligature of the vena
cava and intravenous administration of tissue thromboplastin. Pre-treatment with 100 or 200 mg/kg per day
of the ethanolic extract for 8 weeks significantly prolonged the prothrombin time (PT) in comparison to the
control group (12.1090.35 sec and 14.3890.29 sec vs. 10.890.32 sec, pB0.05 and 0.001, respectively). In
comparison to the control group, the same doses had no statistically significant effect on thrombus weight
(16.8590.67 mg, 16.3290.35 mg, and 17.8190.75 mg; p0.18 and 0.06) or on activated partial
thromboplastin time (APTT) (19.1790.33 sec, 19.1290.73 sec, and 18.9790.41 sec; p0.36 and 0.43,
respectively). One important finding in this study concerns thrombus morphology. In the extract treatment
groups, the thrombus was filament-like and did not adhere to blood vessel walls, whereas in the control group
the thrombus was thick and almost completely occluded the vein. Therefore, these results suggest that OLE
ethanolic extract can modify the extrinsic coagulation pathway as evidenced by the prolongation of PT and
changes in thrombus morphology, enough to justify further research to evaluate its possible antithrombotic
effects.
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T
hromboembolic diseases are serious and life
threatening. Despite the availability of antithrom-
botic drugs for the prevention and treatment of
arterial and venous thrombosis, thrombotic diseases
continue to be a major cause of death and disability
worldwide. Therefore, there remains a need for more
effective therapies to combat these disorders (1).
In the recent years, there has been a growing interest in
using medicinal natural products in the prevention and
treatment of many illnesses, including cardiovascular
disorders. Olive trees (Olea europaea L.) have been widely
cultivated in the Mediterranean countries for the produc-
tion of olive oil. The leaves and fruits contain several
constituents with considerable pharmacological activi-
ties, including polyphenols, flavones, and flavonoids (2).
The most abundant compound in olive leaf (OLE) is
oleuropein, followed by hydroxytyrosol (HT), the fla-
vone-seven-glucosides of luteolin and apigenin, and
verbascoside (3). Other bioactive constituents of OLE
include triterpenes such as oleanolic acid (4) and
flavonoids (rutin and diosmin) (5). Extracts of OLEs
have been studied both in experimental animals and in
humans and have been found to exhibit antimicrobial (6,
7), antidiabetic (8, 9) and anticancer effects (10, 11), and
also to possesses beneficial effects on the cardiovascular
system, including antihypertensive (12), anti-arrythmic
(13), vasodilator (14), hypocholesterolaemic (15), and
hypolipidimic activities (16).
A survey of available literature revealed that most of
the research work done so far on the antithrombotic
effect of the olive plant was on the olive oil. Brzosko et al.
(17) were the first to report in vivo experimental evidence
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of the thrombosis prevention properties of olive oil and
they suggested that this effect may be mediated by
reduced fibrinogen concentrations and impaired
plateletvessel wall interactions. De La Cruz et al. (18)
showed that in hypercholesterolaemic rabbits, dietary
supplementation with olive oil improved lipid profile
and reduced vascular thrombogenicity and platelet acti-
vation. Tsantila et al. (19) have reported similar antith-
rombotic and antitherosclerotic effects of olive oil in
rabbits. Larsen et al. (20), in a randomized clinical study
on healthy volunteers, have demonstrated that diet rich
in olive oil attenuates the acute procoagulant effects of
fatty meals.
Therefore, this work was undertaken to investigate the
possible haemostatic effects of the ethanolic extract of
OLEs using the model of deep vein thrombosis (DVT)
and stasis in rabbits.
Materials and methods
Plant material and extract preparation
OLEs were collected from the pruning of trees in Ejmail
city (north-west Libya) in February 2010. The leaves were
cleaned from extraneous matter, shade-dried at room
temperature with passive ventilation and crushed into a
fine powder. The powder was macerated in ethanol (99%)
and allowed to extract for 48 h. The resultant (dark green-
brown mixture) was filtered and the filtrate was concen-
trated in a rotary evaporator under reduced pressure
(Stuart). The extract residue was stored in an air-tight,
brown glass bottle in a refrigerator. The extraction
procedure was carried out in the laboratories of the
Libyan National Medical Research Centre (Al-Zawia).
The yield of the ethanolic extract was 113.16 g per 1,000 g
fresh leaves.
Animals
Twenty-four healthy, locally inbred adult male white
rabbits (2.43.1 kg) were used. The animals were main-
tained on a regular diet purchased from a local company
(Tahady Factory, Zawia, Libya) and allowed water ad
libitum. The rabbits were randomly divided into four
groups of six animals each. The study was approved by
the Faculty of Pharmacy of Tripoli University, and the
experiments were done according to the ethics guidelines
of the University.
The drugs and the vehicle (water) were administered by
gavage. The first group (positive control) was given
warfarin (1.25 mg/kg per day), the second group was
given OLE at 100 mg/kg per day, and the third group was
given OLE at 200 mg/kg per day. The OLE doses were
prepared by reconstitution of the extract residue in
distilled water (20 mg/ml). The fourth group served as
the negative control and was given distilled water. The
treatments were given for 8 weeks.
Rabbit DVT model
The model of DVT in the rabbit was used and the
antithrombotic activity of the extract was evaluated by its
effect on weight of the thrombus formed in a section of
the vena cava following intravenous injection of throm-
boplastin combined with stasis. Antithrombotic efficacy
was measured as a decrease in the weight of thrombus
formed during a 10-min period.
Rabbits were fasted for 1224 h before the experiments.
After shaving and placing the animals in a supine
position, they were anesthetized by intramuscular injec-
tions of 50 mg/kg of ketamine and 18 mg/kg of xylazine,
supplemented as needed using one-half of the full
induction dose. Venous thrombosis was induced as
previously described (21). The abdomen was opened,
the inferior vena cava was exposed by careful separation
from the surrounding tissue and isolated between the
renal veins and the bifurcation of the inferior vena cava.
Two separate pieces of thread were placed under this
section of the vena cava, 5.5 cm apart. Thromboplastin
(Biolab, France) (0.1 ml/kg) was injected as a bolus in the
right femoral vein. Stasis was accomplished first by tying
the proximal thread on the vena cava and immediately
tying the distal thread. Total time between thromboplas-
tin injection and tying both threads was 18 sec. The stasis
was maintained for 10 min and the thrombus was
harvested by cutting the vena cava longitudinally. The
thrombus was carefully removed, blotted on filter paper,
and weighed (22).
Coagulation analysis and assays
Blood samples were obtained from the marginal ear vein
using vacuum blood tubes containing 3.2% trisodium
citrate (Vacutest, Arzergrande, Italy) 24 h after the last
treatment. Blood was centrifuged at 1,500 rpm for 10 min
at room temperature and the plasma was used for
determination of prothrombin time (PT) and activated
partial thromboplastin time (APTT).
Prothrombin time
PT was determined using a coagulometer (Coatron M1,
Germany). Plasma (25 ml) was pre-warmed for 1 min at
378C and coagulation was initiated by addition of 50 ml of
pre-warmed thromboplastin.
Activated partial thromboplastin time
APTT was determined using a coagulometer (Coatron
M1, Germany). Plasma (25 ml) was incubated for 5 min
with 25 ml of APTT reagent, STA-PTT Automate
(Diagnostika Stago, Asnieres, France), and coagulation
was initiated by addition of 25 ml of pre-warmed calcium
chloride solution.
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Statistical analysis
Data were analyzed with MINITAB 14.0. The results are
reported as mean values9SEM. The data were analyzed
for statistical differences by a one-way analysis of
variance (ANOVA) followed by unpaired Student’s
T-test to determine the level of significance, and p
valuesB0.05 were considered significant.
Results
Effect of OLE on thrombus weight
Treatment with OLE at 100 or 200 mg/kg per day for
8 weeks had no significant effect (p0.05) on thrombus
weight in comparison with the control group treated
with distilled water. The values were 16.8590.67,
16.3290.35, and 17.8190.75 mg, respectively. Warfarin
(1.25 mg/kg) produced a highly significant (pB0.001)
decrease in thrombus weight compared with the control
group (6.9390.30 mg and 17.8190.75 mg, respectively)
(Table 1).
Effect of OLE on coagulation parameters
(PT and APTT)
To investigate the potential interactions of OLE with
coagulation factors, the effects of the extract on coagula-
tion time were evaluated by measuring PT and APTT. In
the negative control group, PT was 10.8090.32 sec.
Administration of OLE resulted in a significant prolon-
gation of PT to 12.1090.35 sec (pB0.05) for the dose of
100 mg/kg per day and to 14.3890.29 sec (pB0.01) for
the dose of 200 mg/kg per day. Warfarin administration
resulted in a significant (pB0.001) prolongation of PT to
26.8390.79 sec as compared to the negative control
group given water (Fig. 1A).
The effect of pre-treatment with OLE on APTT is
shown in Fig. 1B. Both doses (100 and 200 mg/kg
per day) caused only a slight and insignificant increase
(p0.05) in APTT when compared to the control (water-
treated) group. Warfarin, on the other hand, significantly
(pB0.001) prolonged APTT as compared to the negative
control group (Table 1).
An important observation concerning the morphology
of the thrombus is that in the control group treated with
water, the thrombus was thick and caused almost a
completely blocked vein lumen (Fig. 2A), whereas in the
OLE-treated groups the thrombus was thin, filament-like,
and elongated (Fig. 2B).
Discussion
Several antithrombotic agents are available for the
control and treatment of thrombotic diseases, but many
are expensive and possess toxic effects. It is therefore
necessary to search for safe, inexpensive, naturally
occurring agents from plants and other natural sources.
We show that oral pre-treatment of rabbits with 100 mg
or 200 mg/kg OLE for 8 weeks had no effect on APTT
(intrinsic coagulation pathway). However, the same doses
produced a significant prolongation of PT (extrinsic
coagulation pathway). The prolongation of PT was
more prominent with the higher dose of 200 mg/kg
than the smaller dose (pB0.01). This antithrombic
activity of OLE might be due to modification of the
extrinsic but not the intrinsic coagulation system.
The prolongation of PT only suggests an inhibition of
the extrinsic pathway FVII, but mild inhibition of FX,
FV, and FII (23). Inhibition of FVII can be explained by
a direct effect of nitric oxide (NO) downregulating the
factor VII gene (24). Ruano et al. (25) have reported
that in hypercholesterolaemic patients, olive oil (rich in
phenolic compounds) improved the prothrombotic pro-
file and reduced plasma FVII.
Treatment with OLE caused a slight but statistically
insignificant reduction in thrombus weight compared to
the control group. The significant prolongation of PT by
OLE in our study was not linked to any significant effect
on thrombus weight. This result is consistent with the
finding of Gitel and Wessler (26), who demonstrated that
for a drug to have a significant antithrombotic effect, the
PT ratio should be 1.5 or above. Our PT ratios for OLE
doses of 100 and 200 mg/kg per day were 1.12 and 1.33,
respectively. The only difference was in the shape
(morphology) of the thrombus in the different treatment
groups. In the negative control group, the thrombus was
thick, adherent, and almost occluded the whole vessel,
whereas in the treatment groups (both doses), the throm-
bus was thin and filament-like. This difference in throm-
bus morphology may be explained by the finding that
OLE can cause an increase in the release of NO by the
endothelium, preventing platelet adhesion to the vessel
wall (27) and also preventing leukocyte adhesion (28).
The action of locally produced NO is brief due to its very
short half-life and its interaction with haemoglobin,
which makes it effective only in the immediate vicinity
of its site of production (29). Oleuropein, which is the
main constituent of OLE, was found to stimulate nitric
Table 1. Effect of ethanolic extract of olive leaf (OLE) on
thrombus weight in rabbits
Groups Number of animals
Thrombus weight
(mg)
Control (water) 6 17.8190.75
OLE (100 mg/kg) 6 16.8590.67
OLE (200 mg/kg) 6 16.3290.35
Warfarin (1.25 mg/kg) 6 6.9390.3***
Data are expressed as mean9SEM (n6), ***pB0.001 com-
pared to control (water) group.
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acid (NO) production in mouse macrophages and to
activate the inducible form of NO synthase (30). Phe-
nolics in OLE probably contribute to the reduction
of thrombus adhesion to vessel walls by inhibiting
homocysteine-induced endothelial cell adhesion, regard-
less of their antioxidant activity (31).
Another possible explanation for non-adherence of the
thrombi to the vessel walls is that the blood platelets are
in motion and in proximity to endothelial cells may
become unresponsive to agonists. This inhibition of
platelet responsiveness is due to at least three thrombor-
egulatory systems: eicosanoids, endothelial-derived relax-
ing factor (NO), and an ecto-nucleotidase on endothelial
cells that metabolizes the released platelet agonist, ADP.
Removal of ADP eliminates platelet recruitment and
results in return of platelets to the resting state (32).
In addition, prostacyclin (PGI2) synthesized in the wall
of blood vessels could regulate the deposition of platelets
on the vascular wall (33). The increase in PGI2 produc-
tion may be related to the presence of the bioactive
molecule, oleanolic acid, in OLE. Oleanolic acid acts
as a strong inducer of the synthesis and release of
PGI2 in human vascular smooth muscle cells through a
cyclooxygenase-dependent mechanism (34).
Other chemical constituents found in OLE, such as
flavonoids, polyphenols, and hydrotyrosols, may contri-
bute to its effects on platelet function and thrombogeni-
city. Hladovec (35) reported that falvonoids are effective
‘protectors’ in two prethrombotic models (venostatic
thrombosis and arterial thrombosis) in rats. Polyphenols
in OLE have been found to inhibit in vitro platelet
function in the blood of healthy, non-smoking male
volunteers (36). The polyphenols in green tea (37) and
Salvia miltiorrhiza Bunge (38) exhibit potent antithrom-
botic effects, probably due to their scavenging of free
radicals. Moreover, Léger et al. (39) have shown that HT-
rich phenolic extract from olive has an antiaggregating
action on platelets and could prevent thrombotic and
microthrombotic processes.
There are certain limitations in this study. First, we
used crude extract of OLE containing several active
constituents. Future studies are needed to investigate the
antithrombotic effect of these constituents after their
separation. Second, the duration of treatment may be
relatively short and another study with longer periods of
extract administration may provide different results.
In conclusion, this study reports for the first time that
orally administered OLE significantly prolongs PT in
Fig. 2. Thrombus harvested from the vena cava of a control rabbit (A) and from a rabbit treated with olive leaf extract (B).
Fig. 1. Effect of treatment with ethanolic extract of olive leaf (OLE; 100, 200 mg/kg per day for 8 weeks) on prothrombin time
(A) and activated partial thromboplastin time (B) in rabbits. Data are expressed as mean9SEM (n6), *pB0.05; **pB0.01;
***pB0.001 compared to control (water) group.
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the rabbit model of DVT. However, it is premature to
draw conclusions about the potential use of OLE as an
antithrombotic agent in conditions associated with
hyprecoagulopathy state. PT indicates functions of fac-
tors II, V, VII, X, and fibrinogen, so it is worthwhile to
investigate the effect of OLE on these factors. Future
studies will also be needed to determine the effect of OLE
on liver function, especially on the synthesis of pro-
thrombin and other procoagulant proteins. Finally, the
effect of the extract administration on venous and arterial
blood flow may also be evaluated.
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Vasodilator effect of olive leaf. Planta Med. 1991; 57: 4179.
15. Fki I, Bouaziz M, Sahnoun Z, Sayadi S. Hypocholesterolemic
effects of phenolic-rich extracts of Chemlali olive cultivar in
rats fed a cholesterol-rich diet. Bioorg Med Chem. 2005; 13:
536270.
16. Jemai H, Bouaziz M, Fki I, El Feki A, Sayadi S. Hypolipidimic
and antioxidant activities of oleuropein and its hydrolysis
derivative-rich extracts from Chemlali olive leaves. Chem Biol
Interact. 2008; 176: 8898.
17. Brzosko S, De Curtis A, Murzilli S, de Gaetano G, Donati MB,
Iacoviello L. Effect of extra virgin olive oil on experimental
thrombosis and primary hemostasis in rats. Nutr Metab
Cardiovasc Dis. 2002; 12: 33742.
18. De La Cruz JP, Villalobos MA, Carmona JA, Martı́n-Romero
M, Smith-Agreda JM, de la Cuesta FS. Antithrombotic
potential of olive oil administration in rabbits with elevated
cholesterol. Thromb Res. 2000; 100: 30515.
19. Tsantila N, Karantonis HC, Perrea DN, Theocharis SE,
Iliopoulos DG, Antonopoulou S, et al. Antithrombotic and
antiatherosclerotic properties of olive oil and olive pomace polar
extracts in rabbits. Mediators Inflamm. 2007; 2007: 36204.
20. Larsen LF, Jespersen J, Marckmann P. Are olive oil diets
antithrombotic? Diets enriched with olive, rapeseed, or sun-
flower oil affect postprandial factor VII differently. Am J Clin
Nutr. 1999; 70: 97682.
21. Martin DJ, Toce JA, Anevski PJ, Tollefsen DM, Abendschein
DR. Anticoagulant and antithrombotic activity of maltodapoh,
a novel sulfated tetrasaccharide. J Pharmacol Exp Ther. 1999;
288: 51621.
22. Giardino EC, Costanzo MJ, Kauffman JA, Li QS, Maryanoff
BE, Andrade-Gordon P. Antithrombotic properties of rwj-
50353, a potent and novel thrombin inhibitor. Thromb Res.
2000; 98: 8393.
23. Hood JL, Eby CS. Evaluation of a prolonged prothrombin time.
Clin Chem. 2008; 54: 7658.
24. De Lucas SBJ, Bartolome J, Carreno V. Nitric oxide down-
regulates factor VII gene by inhibiting the binding of SP1 and
HNF-4. Hepatology. 2003; 38: 756.
25. Ruano J, Lopez-Miranda J, de la Torre R, Delgado-Lista J,
Fernandez J, Caballero J, et al. Intake of phenol-rich virgin oil
improves the postprandial prothrombic profile in hypercholes-
terolemic patients. Am J Cli Nutr. 2006; 86: 3416.
26. Gitel SN, Wessler S. Dose-dependent antithromboticeffect
ofwarfarin in rabbits. Blood. 1983; 61: 4358.
27. Tanner FC, Largiader T, Greuert H, Yang Z, Luscher TF. Nitric
oxide synthase gene transfer inhibits biological features of
bypass graft disease in the human saphenous vein. J Thorac
Cardiovasc Surg. 2004; 127: 206.
28. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N
Engl J Med. 1998; 338: 104250.
29. Schussheim AE, Fuster V. Thrombosis, antithrombotic agents,
and the antithrombotic approach in cardiac disease. Prog
Cardiovasc Dis. 1997; 40: 20538.
30. Visoli F, Beeosta S, Galli C. Oleuropein, the bitter principle of
olives, enhances nitric oxide production by mouse macrophages.
Life Sci. 1998; 62: 5416.
31. Manna C, Napoli D, Cacciapuoti G, Porcelli M, Zappia V. Olive
oil phenolic compounds inhibit homocysteine-induced endothe-
lial cell adhesion regardless of their antioxidant activity. J Agric
Food Chem. 2009; 57: 347882.
32. Marcus AJ, Broekman JM, Drosopoulos JH, Islam N,
Alyonycheva TA, Safier LB, et al. The endothelial cell ecto-
ADPase responsible for inhibition of platelet function is CD39.
J Clin Invest. 1997; 99: 135160.
Antithrombotic effect of olive leaf extract in rabbits
Citation: Libyan J Med 2013, 8: 20947 - http://dx.doi.org/10.3402/ljm.v8i0.20947 5
(page number not for citation purpose)
33. Weiss HJ, Turitto VT. Prostacyclin (prostaglandin I2, PGI2)
inhibits platelet adhesion and thrombus formation on suben-
dothelium. Blood. 1979; 53: 24450.
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